NCT05726136 - Fluid Challenge and Plasma Volume, During Surgery | Biotech Hunter

Enrollment

60

Participants

Timeline

Start Date

October 23, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

Colorectal CancerUrologic CancerGynecologic CancerColorectal DisordersBenign Neoplasm

Interventions

DRUG

acetated Ringers

After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first fluid bolus is infused. Circulatory and volume effects are studied. If cardiac output increase a second bolus is infused and studied.

DRUG

albumin 5%

After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied.

DRUG

albumin 20%

After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied.

Trial Locations (1)

60379

RECRUITING

Vrinnevi Hospital, Norrköping